Display options
Share it on

Dermatoendocrinol. 2017 Oct 04;9(1):e1361570. doi: 10.1080/19381980.2017.1361570. eCollection 2017.

Modulation of Toll Like Receptor-2 on sebaceous gland by the treatment of adult female acne.

Dermato-endocrinology

Marco A D Rocha, Lilia R S Guadanhim, Adriana Sanudo, Edileia Bagatin

Affiliations

  1. Department of Dermatology, Department of Preventive Medicine, Universidade Federal de São Paulo, São Paulo, Brazil.
  2. Department of Preventive Medicine - Universidade Federal de São Paulo, São Paulo, Brazil.

PMID: 29484093 PMCID: PMC5821154 DOI: 10.1080/19381980.2017.1361570

Abstract

Adult female acne is a chronic inflammatory, immune-mediated disease that affects the pilosebaceous unit in women in their 20s to 40s, and is considered different from acne vulgaris.

Keywords: Acne; azelaic acid; combined oral contraceptive; sebaceous glands; toll-like receptor 2

References

  1. Cutan Ocul Toxicol. 2016 Dec;35(4):300-9 - PubMed
  2. J Clin Aesthet Dermatol. 2013 Sep;6(9):27-35 - PubMed
  3. Int J Med Microbiol. 2017 Feb;307(2):108-112 - PubMed
  4. Br J Dermatol. 2013 Mar;168(3):474-85 - PubMed
  5. Expert Opin Pharmacother. 2017 Feb;18(3):263-273 - PubMed
  6. BMC Dermatol. 2013 Sep 06;13:10 - PubMed
  7. J Invest Dermatol. 2014 Feb;134(2):307-310 - PubMed
  8. Clin Dermatol. 2010 Jan-Feb;28(1):17-23 - PubMed
  9. J Physiol. 2005 Mar 15;563(Pt 3):945-55 - PubMed
  10. Am J Clin Dermatol. 2006;7(5):281-90 - PubMed
  11. J Eur Acad Dermatol Venereol. 2016 May;30(5):824-8 - PubMed
  12. J Am Acad Dermatol. 2016 May;74(5):945-73.e33 - PubMed
  13. Cochrane Database Syst Rev. 2012 Jun 13;(6):CD004425 - PubMed
  14. Dermatoendocrinol. 2009 Mar;1(2):77-80 - PubMed
  15. Exp Dermatol. 2010 Sep;19(9):813-20 - PubMed
  16. Arch Dermatol Res. 2014 Oct;306(8):683-8 - PubMed
  17. Cutis. 2008 Aug;82(2):143-50 - PubMed
  18. Skin Pharmacol Physiol. 2014;27 Suppl 1:1-2 - PubMed
  19. Skin Pharmacol Physiol. 2014;27 Suppl 1:3-8 - PubMed
  20. Arch Dermatol Res. 2015 Dec;307(10):905-15 - PubMed
  21. J Eur Acad Dermatol Venereol. 2013 Sep;27(9):1063-70 - PubMed
  22. Arch Dermatol Res. 2004 Aug;296(3):120-4 - PubMed
  23. Exp Dermatol. 2013 Jan;22(1):41-7 - PubMed
  24. J Invest Dermatol. 2012 Sep;132(9):2198-205 - PubMed
  25. Presse Med. 2008 Apr;37(4 Pt 1):585-91 - PubMed
  26. Anal Quant Cytopathol Histpathol. 2014 Apr;36(2):100-10 - PubMed
  27. Indian J Dermatol Venereol Leprol. 2013 May-Jun;79(3):322-37 - PubMed
  28. J Eur Acad Dermatol Venereol. 2011 Apr;25(4):454-61 - PubMed
  29. J Am Acad Dermatol. 2010 Nov;63(5):782-8 - PubMed
  30. Dermatology. 2005;211(3):193-8 - PubMed
  31. Egypt J Immunol. 2009;16(1):127-34 - PubMed
  32. J Am Acad Dermatol. 2013 Jun;68(6):1022-9 - PubMed
  33. Exp Dermatol. 2009 Oct;18(10):821-32 - PubMed
  34. J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1096-106 - PubMed
  35. J Clin Aesthet Dermatol. 2017 Jan;10 (1):37-46 - PubMed
  36. J Invest Dermatol. 2005 Jul;125(1):1-8 - PubMed
  37. J Eur Acad Dermatol Venereol. 2012 Mar;26(3):277-82 - PubMed
  38. J Am Acad Dermatol. 2008 Jan;58(1):56-9 - PubMed
  39. J Drugs Dermatol. 2008 Jan;7(1):13-6 - PubMed
  40. Ann Intern Med. 2005 Nov 15;143(10):697-706 - PubMed
  41. Eur J Dermatol. 2011 May-Jun;21(3):323-33 - PubMed
  42. Inflamm Allergy Drug Targets. 2014;13(3):162-7 - PubMed
  43. Exp Dermatol. 2007 Jun;16(6):500-6 - PubMed
  44. Obstet Gynecol. 2008 Oct;112(4):773-81 - PubMed
  45. Obstet Gynecol. 2012 May;119(5):1039-44 - PubMed
  46. Br J Dermatol. 2005 Dec;153(6):1105-13 - PubMed
  47. J Drugs Dermatol. 2012 Jun;11(6):708-13 - PubMed
  48. J Eur Acad Dermatol Venereol. 2015 Apr;29(4):789-96 - PubMed

Publication Types